The All Ordinaries Index (ASX: XAO) is back in the green on Wednesday, driven higher by four shares leaping to new 52-week highs.
Right now, the All Ordinaries Index is up 0.12%, trading at 7,606.9 points.
Let's take a closer look at four shares trading at their highest point in more than a year today.
4 ASX All Ordinaries shares soaring to 52-week highs
The Stanmore Resources Ltd (ASX: SMR) share price is on the up and up today, gaining 5% at its intraday peak to hit an all-time record high of $3.55.
The coal miner has been on a major roll over the last 12 months, gaining more than 230% in that time.
Joining the coal miner in the green is All Ordinaries biopharmaceutical share Clinuvel Pharmaceuticals Limited (ASX: CUV). It soared 3% earlier today to reach $26.65 – the highest it's been since this time last year.
The last 12 months have been a rollercoaster for the healthcare stock. Six months before it soared to today's high, the stock hit a low of $13.16.
Clinuvel isn't the only All Ordinaries biopharma share posting 52-week highs today.
The share price of Neuren Pharmaceuticals Ltd (ASX: NEU) also surged to a multi-year high of $9.08 earlier today. That marked a 1.6% gain on its previous close.
The last time the stock traded at such levels was in 2007 – before the Global Financial Crisis took hold of markets around the world.
The final ASX All Ordinaries share soaring to long-forgotten highs is Aroa Biosurgery Ltd (ASX: ARX). It surged to $1.20 in afternoon trade – a 1.7% gain on its previous closing price.
The company listed on the ASX following its $45 million initial public offering (IPO) in mid-2020. Investors who got on board in its IPO did so for just 75 cents per share.
